High NRF2 activity is found predominantly in cancers associated with carcinogen exposure including non-small cell lung cancer (NSCLC), esophageal cancer, endometrial carcinoma, bladder cancer, and head and neck cancers [13]. This evidence concerns the gene NFE2L2 and urinary bladder carcinoma.